Stock FBIOP FORTRESS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Fortress Biotech, Inc. Nasdaq

Equities

FBIOP

US34960Q2084

Market Closed - Nasdaq
Other stock markets
 15:58:22 2024-06-07 EDT 		5-day change 1st Jan Change
16.73 USD +1.70% Intraday chart for Fortress Biotech, Inc. +5.42% +40.94%
05-15 Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-15 Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
AQ
Fortress Biotech: Q1 Earnings Snapshot
AQ
Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M
MT
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
AQ
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
AQ
Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex
MT
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
AQ
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
CI
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
AQ
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
AQ
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
AQ
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
AQ
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
AQ
Avenue Therapeutics Announces Reverse Stock Split
AQ
North American Morning Briefing : Powell Awaited -2-
DJ
Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
CI
Certain Options of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
CI
Certain Common Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
CI
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FBIO Stock
  4. FBIOP Stock
  5. News Fortress Biotech, Inc.